Term ends Sep 26, 2028 · High confidence
20-year base term ends Sep 26, 2028
Filed Jul 2, 2015 as application 14/790,305 · Granted Mar 7, 2017
Base term, 20 years from filing
Today
2008
2028
Clock starts
Sep 26, 2008
Sep 26, 2008
Term ends
Sep 26, 2028
Sep 26, 2028
Granted
Mar 7, 2017
Mar 7, 2017
base term
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 9,109,046, to Sep 26, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
14
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Sep 26, 2008, when application 12/239,651, the earliest non-provisional in its chain, was filed (this one was filed Jul 2, 2015) | Sep 26, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 9,109,046) | resolves to Sep 26, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Sep 26, 2028 | High confidence |
This family
| US 8,153,590 | In force Jan 2034 | Jan 2034 |
| US 8,268,783 | In force Feb 2029 | Feb 2029 |
| US 8,455,441 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,109,046 | In force Jan 2029 | Jan 2029 |
| US 9,062,298 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 8,889,129 | In force no later than Sep 2028 | no later than Sep 2028 |
| US 9,388,401 | In force Sep 2028 | Sep 2028 |
| US 9,587,233 | this patent Sep 2028 | Sep 2028 |
8 of 14 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 2, 2015 Reel 35971, frame 427 | Sinha, Uma; Lu, Genmin; Conley, Pamela B. | Portola Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Mar 18, 2019 Reel 48633, frame 673 | Portola Pharmaceuticals, Inc. | HCR Collateral Management, LLC | Security Interest |
| Jul 2, 2020 Reel 53120, frame 925 | HCR Collateral Management, LLC | Portola Pharmaceuticals, Inc. | Release of Security Interest |
| Jan 7, 2021 Reel 54920, frame 739 | Portola Pharmaceuticals, Inc. | Portola Pharmaceuticals, LLC | Change of Name |
| Jan 7, 2021 Reel 54921, frame 131 | Portola Pharmaceuticals, LLC | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jan 7, 2021 Reel 54922, frame 857 | Alexion Pharma International Operations Unlimited Company | Alexion Pharmaceuticals, Inc. | Assignment of Assignor's Interest |
| Jul 21, 2022 Reel 60799, frame 729 | Alexion Pharmaceuticals, Inc. | Alexion Pharma International Operations Unlimited Company | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Sep 2028
Term ends Sep 26, 2028. No further fees fall due before then
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 9,109,046, ends no earlier than this term, so it caps nothing.
Citations
13
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.